|
ASIA PACIFIC PHARMA CONGRESS
AGENDA: PRECONFERENCES
Tuesday, September 13, 2011
|
PRECONFERENCE SYMPOSIA
(Participation Optional; Separate Registration; Two Concurrent Precons; Choose One)
|
|
8:00 a.m. |
Registration Commences
|
|
PRECONFERENCE I: ASIA PACIFIC CODE UPDATE
|
|
9:00 a.m. |
Welcome and Introductions
Maija Burtmanis, LLB, LLM
Regional Counsel, Japan/Asia Pacific, Novartis Vaccines; Former Regional Counsel, Pfizer Asia, Singapore, (Co chair)
Lim Kai Toh, MD
Medical Affairs Manager, Pfizer, Singapore (Co chair)
|
|
9:15 a.m. |
The IFPMA Code of Pharmaceutical Marketing Practices and Its Relevance in Asia
Lim Kai Toh, MD
Medical Affairs Manager, Pfizer, Singapore
|
|
9:30 a.m. |
Medicines Australia
Maija Burtmanis, Esq.
Regional Counsel, Japan/Asia Pacific, Novartis Vaccines; Former Regional Counsel, Pfizer Asia, Singapore
Presentation Material (Acrobat)
|
|
9:45 a.m. |
Revised RDPAC Code in January 2011 - China
Yuet-Ming Tham, Esq.
Partner and Head, Regulatory, Compliance & Investigations Group, Asia, DLA Piper LLP, Hong Kong
|
|
10:00 a.m. |
New Code Approved by the Korea Fair Trade Commission in April 2010 - Korea
Kyle Choi, Esq.
Health Law Group, Kim & Chang, Seoul, South Korea
|
|
10:15 a.m. |
Break
|
|
10:30 a.m. |
MCI for India
Arpinder Singh
Partner and National Director, Ernst & Young, Mumbai, India
Presentation Material (Acrobat)
|
|
10:45 a.m. |
Constructive Navigation in a Changing Environment - Lessons Learnt
Paul Vibert, MBA
Senior Vice President, Asia Pacific, Ferring Pharmaceuticals, Shanghai, China
Yuet-Ming Tham, Esq.
Partner and Head, Regulatory, Compliance & Investigations Group, Asia, DLA Piper LLP, Hong Kong
Presentation Material (Acrobat)
|
|
11:10 a.m. |
Faculty Q&A
|
|
12:00 p.m. |
Adjournment and Lunch on Your Own
|
|
|
|
PRECONFERENCE II: ASIA PACIFIC TRANSPARENCY, DISCLOSURE AND AGGREGATE SPEND ISSUES
|
|
9:00 a.m. |
Welcome and Introductions and Global Transparency and Disclosure Overview
William E. Buzzeo, MS
Vice President and General Manager, Global Compliance Solutions, Cegedim Relationship Management, Richmond, VA, USA (Co chair)
Presentation Material (Acrobat)
|
|
9:30 a.m. |
Global Compliance Strategies
Jennifer Colapietro
Partner, Transparency and Aggregate Spend Practice Lead, PricewaterhouseCoopers LLP, Florham Park, NJ, USA
David Wysocky
Director, Pharmaceutical and Life Sciences Compli-ance Practice, PricewaterhouseCoopers LLP, Florham Park, NJ, USA
|
|
10:15 a.m. |
Break
|
|
10:30 a.m. |
Transparency in Japan
Kevin Yamaga-Karns, Esq.
Senior Director of Legal Affairs & Compliance, Eli Lilly Japan KK, Kobe, Japan
Presentation Material (Acrobat)
|
|
11:00 a.m. |
GSK Transparency Initiative in Australia
Kevin Foo
Area Compliance Officer - Asia Pacific, GlaxoSmithKline, Singapore
Presentation Material (Acrobat)
|
|
11:30 a.m. |
Faculty Q&A
|
|
12:00 p.m. |
Adjournment and Lunch on Your Own
|
AGENDA: DAY I
Tuesday, September 13, 2011
|
|
OPENING PLENARY SESSION
|
|
1:00 p.m. |
Welcome and Introductions: Asia Pacific Pharma Congress Vision and Overview: Implementing Compliance Best Practices Across an Immense Geographic Region with Many Cultural Differences
Manuel Flores
Compliance Director Asia Pacific, Bayer (South East Asia) Pte Ltd, Singapore (Co chair)
Abdul Luheshi, MBA
Vice President Health Care Compliance, Asia Pacific, Johnson & Johnson, Singapore (Co chair)
Maria "Maru" Quindimil, MBA
AP & China Regional Compliance Officer, Merck Sharp and Dohme (Asia Ltd.), Manila, Philippines (Co chair)
Kelly B. Freeman, PhD
Ethics and Compliance Officer, Eli Lilly and Company; Executive Committee Member, Pharmaceutical Compliance Forum, Indianapolis, IN, USA (PCF Liaison)
|
|
1:30 p.m. |
Establishing a Culture of Compliance in Emerging Markets
Kim Taylor
Company Group Chairman, Johnson & Johnson, Pharmaceuticals, Asia Pacific, Singapore
Presentation Material (Acrobat)
|
|
2:00 p.m. |
Overview of Asia Pacific Pharma and Device Compliance Trends
Sabina Sudan
Vice President, Compliance Officer - Emerging Markets, Asia Pacific (EMAP) & Japan, GlaxoSmithKline Pte Ltd., Singapore
Presentation Material (Acrobat)
Jessie Yap, Esq.
Chief Compliance Counsel, Asia Pacific/General Counsel, Australia & New Zealand, Covidien, Lane Cove, Australia
Presentation Material (Acrobat)
|
|
2:45 p.m. |
Asia Pacific Hot Issue: Company Compliance Programmes with Respect to Third Party Intermediaries
Ronald Goon
Senior Director, Business Practices & Compliance, Office of Health Care Compliance & Privacy, Johnson & Johnson, Singapore
Presentation Material (Acrobat)
|
|
3:15 p.m. |
Break
|
|
3:45 p.m. |
What is the 'Right Thing'? The Cultural Translation of Compliance
Hui Chen, Esq.
Senior Corporate Counsel, Asia-Pacific Regional Lead, International Compliance Investigations, Pfizer, New York, NY, USA
Presentation Material (Acrobat)
|
|
4:15 p.m. |
Evaluating the Implications of the Whistleblower Reward Scheme (Dodd-Frank Act) on Your Compliance Program
John T. Bentivoglio, Esq.
Partner, Skadden Arps LLP; Former Special Counsel for Healthcare Fraud and Chief Privacy Officer, US Department of Justice, Washington, DC, USA
Presentation Material (Acrobat)
|
|
4:45 p.m. |
My Experience and Views on Development and Implementation of a Global Ethics and Compliance Program
Anwar Hashmi
Senior Manager - Ethics, Tata Steel, Ltd., Jamshedpur, India
|
|
5:15 p.m. |
Adjournment and Networking Reception
|
|
|
